Circulating Tumor DNA Test Evaluated for Predicting Stage III Recurrence Skip to content The CRC Digest ♥ LIVING WITH CRC Circulating Tumor DNA Test Evaluated for Predicting Stage III Recurrence The α-CORRECT study evaluated a blood test for circulating tumor DNA in patients with stage III colorectal cancer after surgery and chemotherapy to detect tiny traces of cancer that may signal
CRC Research Finding Skip to content The CRC Digest ▪ Personalized ctDNA Test Detects Stage III Recurrence Before Imaging A case series of four stage III CRC patients showed the Signatera ctDNA assay detected recurrence earlier than imaging and informed curative interventions. (Cancer Diagnosis & Prognosis) This content is informational only and does not